TALKING about their below-the-belt health isn’t exactly a chat most men are rushing to have. But the fact remains that ...
In some instances, a man's prostate cancer biopsy can indicate perineural invasion. In an exclusive interview, an expert ...
About 13% of American men will develop prostate cancer at some point, putting their erectile function at risk.
Prostate Artery Embolization (PAE) offers a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). Suitable for ...
News Medical on MSN3d
PROTAC technology offers hope for treating castration-resistant prostate cancerAnnouncing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.
Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.
Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.
New stats from Prostate Cancer UK suggest it is now the most common cancer in England with diagnoses of the disease ...
News Medical on MSN9d
Study highlights potential of genomic tests for early stage prostate cancerA new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...
Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results